- Home
- FOXF vs SPRY Comparison
FOXF vs SPRY Comparison
Compare FOXF & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- SPRY
- Stock Information
- Founded
- FOXF 2007
- SPRY 2015
- Country
- FOXF United States
- SPRY United States
- Employees
- FOXF N/A
- SPRY N/A
- Industry
- FOXF Motor Vehicles
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- FOXF Consumer Discretionary
- SPRY Health Care
- Exchange
- FOXF Nasdaq
- SPRY Nasdaq
- Market Cap
- FOXF 1.2B
- SPRY 1.1B
- IPO Year
- FOXF N/A
- SPRY N/A
- Fundamental
- Price
- FOXF $28.62
- SPRY $12.57
- Analyst Decision
- FOXF Buy
- SPRY Strong Buy
- Analyst Count
- FOXF 6
- SPRY 4
- Target Price
- FOXF $40.33
- SPRY $26.00
- AVG Volume (30 Days)
- FOXF 609.9K
- SPRY 1.5M
- Earning Date
- FOXF 02-20-2025
- SPRY 11-13-2024
- Dividend Yield
- FOXF N/A
- SPRY N/A
- EPS Growth
- FOXF N/A
- SPRY N/A
- EPS
- FOXF 0.26
- SPRY N/A
- Revenue
- FOXF $1,373,579,000.00
- SPRY $2,568,000.00
- Revenue This Year
- FOXF N/A
- SPRY $66,750.00
- Revenue Next Year
- FOXF $4.16
- SPRY $508.63
- P/E Ratio
- FOXF $111.02
- SPRY N/A
- Revenue Growth
- FOXF N/A
- SPRY 8460.00
- 52 Week Low
- FOXF $26.76
- SPRY $6.00
- 52 Week High
- FOXF $69.47
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- FOXF 42.02
- SPRY 58.86
- Support Level
- FOXF $27.67
- SPRY $11.00
- Resistance Level
- FOXF $28.99
- SPRY $12.48
- Average True Range (ATR)
- FOXF 1.12
- SPRY 0.81
- MACD
- FOXF 0.04
- SPRY 0.28
- Stochastic Oscillator
- FOXF 42.13
- SPRY 84.95
About FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.